U.S. FDA approves BioDelivery's drug for opioid dependence

class="mandelbrot_refrag">BioDelivery Sciences International Inc said it had received U.S. regulatory approval for its drug, Bunavail, to treat opioid dependence.

_0">

The company's shares rose 8.5 percent to $10.85 in extended trading on Friday.

BioDelivery said it expects to launch the drug late in the third quarter ending Sept. 30.

 
 
 

Opioid dependence affects more than 2 million people in the United States.

(Reporting by Shailesh Kuber in Bangalore; Editing by Maju Samuel)

Popular posts from this blog

'I was his Christian Grey fantasy.' Ex-girlfriend Paige Lorenze says Armie Hammer carved an A into her groin area as she warns 'narcissistic' actor could 'seriously injure another woman' with his BDSM obsession

Model Stella Tennant dies 'suddenly' aged 50 as her family pay tribute to 'wonderful woman and an inspiration to us all'

Teenage boy, 15, charged after allegedly having sex with two 12-year-old girls and recording the encounter on his phone - but he's still allowed to go to school with them while on bail